Tag: AHA

ReCor Medical announces consistent reduction of blood pressure in pooled analysis...

ReCor Medical and its parent company, Otsuka Medical Devices, announced consistent and significant blood pressure-lowering results across a range of patients with uncontrolled hypertension,...

SPYRAL HTN-ON MED study demonstrates meaningful clinical benefits consistent with other...

Medtronic has announced the six-month results from the full cohort of the SPYRAL HTN-ON MED clinical trial. The late-breaking data were presented at the...

Mechanical thrombectomy shown to restore more function than medication alone following...

A new study from Japan has become the first randomised controlled trial (RCT) to demonstrate the effectiveness of endovascular mechanical thrombectomy procedures in patients...

Amputation rates higher for people with PAD who are poor or...

Poverty and Black race were associated with higher rates of lower leg amputation among people with peripheral arterial disease (PAD) who live in metropolitan areas, according...

AHA scientific statement provides update on epidemiology, diagnosis, and management of...

The American Heart Association (AHA) has released a new scientific statement on lower extremity peripheral arterial disease (PAD), focusing on contemporary epidemiology, management gaps,...
cigarette

Smoking cigarettes associated with increased risk of peripheral arterial disease in...

African Americans who smoke cigarettes are more likely than those who do not smoke to develop peripheral arterial disease (PAD), according to new research...

New ischaemic stroke guidelines widen mechanical thrombectomy window to 24 hours...

The American Heart Association and American Stroke Association released updated ischaemic stroke guidelines that were published in Stroke, and released during the International Stroke...